Fulcrum Therapeutics, Inc.
Public company- Headquarters
- CAMBRIDGE, Massachusetts
- Ticker
- FULC
- CIK
- 0001680581
WARN notices since 2024
0
None on record
Workers affected since 2024
0
Across 0 notices
Executive changes, last 12 months
2
1 appointment, 1 departure
Last event
Aug 10, 2026
Executive departureVice President, Finance and principal accounting officer departs: Greg Tourangeau
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Vice President, Finance and principal accounting officerGreg Tourangeau | Aug 10, 2026 | Departed |
| principal accounting officerAlan Musso | Aug 10, 2026 | Appointed |
Related companies
Same industry and state, with recent events.
- ENANTA PHARMACEUTICALS INC
CEO departs: Jay R. Luly, Ph.D.
- VERTEX PHARMACEUTICALS INC / MA
new member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
member of the Board appointed: Robert J. Spiegel, M.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
No events of this type on record.
Show all eventsLast verified Nov 8, 2026